01
Toxicological Profiling
Before a physical prototype is made, every proposed ingredient undergoes a theoretical toxicological assessment to rule out mutagenic, carcinogenic, or endocrine-disrupting potential.
Zero-Harm Philosophy
Safety & Testing Protocols
Efficacy is meaningless without absolute safety. Every Alizglow formulation is subjected to rigorous toxicological and dermatological vetting to ensure absolute compatibility with human skin physiology.
The Four-Stage Vetting Process
Our safety protocols exceed baseline cosmetic regulations, aligning with stringent global pharmaceutical safety thresholds.
02
In-Vitro Irritancy Testing
We utilize reconstructed human epidermis (RhE) models to test for cellular viability and potential irritation without the use of animal testing.
03
HRIPT (Human Repeat Insult Patch Test)
Conducted on a diverse panel of human volunteers to identify any potential for allergic contact dermatitis or delayed sensitization.
04
Ocular & Phototoxicity
Ensuring formulations are safe near the delicate eye contour and do not cause adverse reactions when exposed to UV radiation.
Formulation Integrity
The Exclusion Matrix
What we leave out of our formulations is just as important as what we include. To minimize the risk of sensitization and ensure long-term skin health, Alizglow strictly prohibits the use of over 2,000 questionable compounds, anticipating future global regulatory shifts.
CDSCO Compliant
ESMA Registered
EU Cosmetic Regulation Aligned
100% Cruelty-Free
Parabens & Phthalates
Excluded due to potential endocrine disruption.
Synthetic Fragrances
The leading cause of contact dermatitis in cosmetics.
Sulfates (SLS/SLES)
Aggressive surfactants that strip the lipid barrier.
Formaldehyde Releasers
Sensitizing preservatives strictly banned from our labs.
Microplastics
Excluded to protect both the skin barrier and marine ecosystems.
Synthetic Dyes
Unnecessary aesthetic additives with no clinical benefit.